New patent for APGDI drug MYRBETRIQ

Annual Drug Patent Expirations for MYRBETRIQ Myrbetriq is a drug marketed by Apgdi and is included in one NDA. It is available from three suppliers. There are seven patents protecting…

The post New patent for APGDI drug MYRBETRIQ appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Do NOT follow this link or you will be banned from the site!